BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16968407)

  • 1. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Van Weyenbergh J; Correa-Oliveira R
    Clin Exp Immunol; 2006 Oct; 146(1):124-32. PubMed ID: 16968407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Correa-Oliveira R
    Scand J Immunol; 2005 Nov; 62(5):487-95. PubMed ID: 16305646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE; Ng W; Wilson CB; McMaster WR; Burchett SK
    J Clin Invest; 1990 Jun; 85(6):1914-24. PubMed ID: 2112157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis.
    Costa AS; Costa GC; Aquino DM; Mendonça VR; Barral A; Barral-Netto M; Caldas Ade J
    Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):735-9. PubMed ID: 22990961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
    Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
    BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy.
    Cenini P; Berhe N; Hailu A; McGinnes K; Frommel D
    J Infect Dis; 1993 Oct; 168(4):986-93. PubMed ID: 8376845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
    Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
    Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.
    de Medeiros IM; Castelo A; Salomão R
    Rev Inst Med Trop Sao Paulo; 1998; 40(1):31-4. PubMed ID: 9713135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
    Gatto M; de Abreu MM; Tasca KI; de Assis Golim M; da Silva LD; Simão JC; Fortaleza CM; de Campos Soares ÂM; Calvi SA
    PLoS One; 2015; 10(2):e0117977. PubMed ID: 25706930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis.
    Singh OP; Stober CB; Singh AK; Blackwell JM; Sundar S
    PLoS Negl Trop Dis; 2012; 6(10):e1874. PubMed ID: 23150744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular profile of cytokine production in a patient with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines and interleukin-10.
    Lagler H; Willheim M; Traunmüller F; Wahl K; Winkler H; Ramharter M; Graninger W; Winkler S
    Scand J Immunol; 2003 Mar; 57(3):291-5. PubMed ID: 12641659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR; Bimal S; Siddiqui NA; Kumar A; Pandey K; Sinha SK; Topno RK; Mahentesh V; Singh AK; Lal CS; Singh SK; Das P
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
    Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
    Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
    Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokines associated with severity and complications of kala-azar.
    Costa DL; Rocha RL; Carvalho RM; Lima-Neto AS; Harhay MO; Costa CH; Barral-Neto M; Barral AP
    Pathog Glob Health; 2013 Mar; 107(2):78-87. PubMed ID: 23683334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.